Researchers have demonstrated that PD-1 expression in itself can be considered a marker of activated tumor-reactive T cells 48, while exhausted T cells that are highly associated with CD8+ T cell dysfunction gain co-expression of multiple checkpoint inhibitory receptors including PD-1, TIM-3, and LAG-3 49, 50. Here, PDCD1 is linked to neoplasm.